×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OCUP – ocuphire pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OCUP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/25
12:00 pm
ocup
The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics
Neutral
Report
The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics
10/23
02:40 pm
ocup
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $10.00. They now have a "buy" rating on the stock.
10/23
09:05 am
ocup
Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders
High
Report
Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders
10/22
04:05 pm
ocup
Ocuphire Pharma Announces Acquisition of Opus Genetics
High
Report
Ocuphire Pharma Announces Acquisition of Opus Genetics
9/30
08:00 am
ocup
Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
Low
Report
Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
9/5
08:52 pm
ocup
UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia [Yahoo! Finance]
Medium
Report
UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia [Yahoo! Finance]
9/5
08:43 pm
ocup
UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
Medium
Report
UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
9/5
08:00 am
ocup
Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
Low
Report
Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
10/24
05:59 pm
ocup
Form 4 Opus Genetics, Inc. For: Oct 22 Filed by: Graves Adrienne L
Neutral
Report
Form 4 Opus Genetics, Inc. For: Oct 22 Filed by: Graves Adrienne L
10/24
05:57 pm
ocup
Form 4 Opus Genetics, Inc. For: Oct 22 Filed by: Bennett Jean
Neutral
Report
Form 4 Opus Genetics, Inc. For: Oct 22 Filed by: Bennett Jean
10/24
05:55 pm
ocup
Form 3 Opus Genetics, Inc. For: Oct 22 Filed by: YERXA BENJAMIN R
Neutral
Report
Form 3 Opus Genetics, Inc. For: Oct 22 Filed by: YERXA BENJAMIN R
10/24
05:52 pm
ocup
Form 3 Opus Genetics, Inc. For: Oct 22 Filed by: Graves Adrienne L
Neutral
Report
Form 3 Opus Genetics, Inc. For: Oct 22 Filed by: Graves Adrienne L
10/24
05:49 pm
ocup
Form 3 Opus Genetics, Inc. For: Oct 22 Filed by: Bennett Jean
Neutral
Report
Form 3 Opus Genetics, Inc. For: Oct 22 Filed by: Bennett Jean
10/22
05:09 pm
ocup
Form 8-K Ocuphire Pharma, Inc. For: Oct 22
High
Report
Form 8-K Ocuphire Pharma, Inc. For: Oct 22
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: